High expression of CCT2 was noted in rhabdomyosarcoma, choroid plexus carcinoma, high-grade glioma/astrocytoma, medulloblastoma, metastatic secondary tumors, neuroblastomas, and others, Figure 1C. Here, CCT2 is linked to neuroblastoma.